This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berchtold, S. Articles by Groner, B. Search for Related Content PubMed PubMed Citation Articles by Berchtold, S. Articles by Groner, B.

Dominant Negative Variants of the SHP-2 Tyrosine Phosphatase Inhibit Prolactin Activation of Jak2 (Janus Kinase 2) and Induction of Stat5 (Signal Transducer and Activator of Transcription 5)-Dependent Transcription

Institute for Experimental Cancer Research (S.B., R.M., B.G.) Tumor Biology Center and Department of Biology University of Freiburg 79106 Freiburg, Germany
Novartis Inc. (S.V., M.M.) CH 4002 Basel, Switzerland

PRL plays a central role in the regulation of milk protein gene expression in mammary epithelial cells and in the growth and differentiation of lymphocytes. It confers its activity through binding to a specific transmembrane, class I hematopoietic receptor. Ligand binding leads to receptor dimerization and activation of the tyrosine kinase Jak (janus kinase) 2, associated with the membrane-proximal, intracellular domain of the receptor. Jak2 phosphorylates and activates Stat5, a member of the Stat (signal transducers and activators of transcription) family. PRL receptor also activates SHP-2, a cytosolic tyrosine phosphatase. We investigated the connection between these two signaling events and derived a dominant negative mutant of SHP-2 comprising the two SH2 domains [SHP-2(SH2)2]. An analogous variant of the SHP-1 phosphatase [SHP-1(SH2)2] was used as a control. The dominant negative mutant of SHP-2 was found to inhibit the induction of tyrosine phosphorylation and DNA-binding activity of m-Stat5a, m-Stat5b, and the carboxyl-terminal deletion variant m-Stat5a749, as well as the transactivation potential of m-Stat5a and m-Stat5b. The dominant negative mutant SHP-1(SH2)2 had no effect. The kinase activity of Jak2 is also dependent on a functional SHP-2 phosphatase. We propose that SHP-2 relieves an inhibitory tyrosine phosphorylation event in Jak2 required for Jak2 activity, Stat5 phosphorylation, and transcriptional induction.

This article has been cited by other articles:

				Y. Ke, J. Lesperance, E. E. Zhang, E. A. Bard-Chapeau, R. G. Oshima, W. J. Muller, and G.-S. Feng Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation J. Biol. Chem., November 10, 2006; 281(45): 34374 - 34380. [Abstract] [Full Text] [PDF]

				N. Akhtar and C. H. Streuli Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia J. Cell Biol., June 5, 2006; 173(5): 781 - 793. [Abstract] [Full Text] [PDF]

				M. Arnaud, C. Crouin, C. Deon, D. Loyaux, and J. Bertoglio Phosphorylation of Grb2-Associated Binder 2 on Serine 623 by ERK MAPK Regulates Its Association with the Phosphatase SHP-2 and Decreases STAT5 Activation J. Immunol., September 15, 2004; 173(6): 3962 - 3971. [Abstract] [Full Text] [PDF]

				S. Ali, Z. Nouhi, N. Chughtai, and S. Ali SHP-2 Regulates SOCS-1-mediated Janus Kinase-2 Ubiquitination/Degradation Downstream of the Prolactin Receptor J. Biol. Chem., December 26, 2003; 278(52): 52021 - 52031. [Abstract] [Full Text] [PDF]

				C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]

				N. Chughtai, S. Schimchowitsch, J.-J. Lebrun, and S. Ali Prolactin Induces SHP-2 Association with Stat5, Nuclear Translocation, and Binding to the beta -Casein Gene Promoter in Mammary Cells J. Biol. Chem., August 16, 2002; 277(34): 31107 - 31114. [Abstract] [Full Text] [PDF]

				N. Aoki and T. Matsuda A Nuclear Protein Tyrosine Phosphatase TC-PTP Is a Potential Negative Regulator of the PRL-Mediated Signaling Pathway: Dephosphorylation and Deactivation of Signal Transducer and Activator of Transcription 5a and 5b by TC-PTP in Nucleus Mol. Endocrinol., January 1, 2002; 16(1): 58 - 69. [Abstract] [Full Text] [PDF]

				C V Clevenger and J B Kline Prolactin receptor signal transduction Lupus, October 1, 2001; 10(10): 706 - 718. [Abstract] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				C. A. Peters, E. T. Maizels, M. C. Robertson, R. P.C. Shiu, M. S. Soloff, and M. Hunzicker-Dunn Induction of Relaxin Messenger RNA Expression in Response to Prolactin Receptor Activation Requires Protein Kinase C {delta} Signaling Mol. Endocrinol., April 1, 2000; 14(4): 576 - 590. [Abstract] [Full Text]

				C.-L. Yu, Y.-J. Jin, and S. J. Burakoff Cytosolic Tyrosine Dephosphorylation of STAT5. POTENTIAL ROLE OF SHP-2 IN STAT5 REGULATION J. Biol. Chem., January 7, 2000; 275(1): 599 - 604. [Abstract] [Full Text] [PDF]

				A. Pezet, H. Favre, P. A. Kelly, and M. Edery Inhibition and Restoration of Prolactin Signal Transduction by Suppressors of Cytokine Signaling J. Biol. Chem., August 27, 1999; 274(35): 24497 - 24502. [Abstract] [Full Text] [PDF]

				N. Aoki and T. Matsuda A Cytosolic Protein-tyrosine Phosphatase PTP1B Specifically Dephosphorylates and Deactivates Prolactin-activated STAT5a and STAT5b J. Biol. Chem., December 8, 2000; 275(50): 39718 - 39726. [Abstract] [Full Text] [PDF]

				S. Ali and S. Ali Recruitment of the Protein-tyrosine Phosphatase SHP-2 to the C-terminal Tyrosine of the Prolactin Receptor and to the Adaptor Protein Gab2 J. Biol. Chem., December 8, 2000; 275(50): 39073 - 39080. [Abstract] [Full Text] [PDF]